Lombard Odier Asset Management (USA) Corp - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (USA) Corp ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$2,424,000
-7.7%
175,0000.0%0.19%
-22.3%
Q1 2017$2,625,000
+100.4%
175,000
+75.0%
0.25%
+48.8%
Q4 2016$1,310,000
-56.6%
100,000
-42.9%
0.17%
-40.5%
Q3 2016$3,015,000
+22.8%
175,000
+90.3%
0.28%
+17.2%
Q4 2015$2,455,000
-14.4%
91,938
-21.8%
0.24%
-4.8%
Q3 2015$2,867,000
-51.6%
117,500
-38.2%
0.25%
-40.6%
Q2 2015$5,920,000190,0000.42%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders